Barely Significant
← all excerpts

Tezepelumab in severe asthma: chest computed tomography assessment of airway remodeling and clinical remission.

Front Pharmacol · 2026 · PMC12901456 · PMID 41693791

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp < 0.0001actually significant
MPS decreased from 5.36 ± 2.85 at baseline to 3.94 ± 2.69 at one-year follow-up, thus undergoing a highly significant change (p < 0.0001) ( Figure 5A ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.